Effects of 5 yr of GH substitution in 118 GH-deficient adults on serum concentrations of TC, HDL-C, LDL-C and TG as well as on blood glucose, serum insulin.

Slides:



Advertisements
Similar presentations
Cinnamon: Not Your Grandma’s Spice Anymore Christie Seibert, MD Primary Care Conference May 14, 2008.
Advertisements

Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Philip J. Barter, et al. Circulation 2011;124:
* Indicates p < 0.05 indicates p < 0.05 Evaluating Clinical Pharmacist Impact on Diabetes Control* Mary Ella Hill, Pharm. D. Candidate; Orijane Dalton,
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA.
Increasing Annual Cost of Diabetes
Features of adult GH deficiency Improved by GH replacement?
Adverse Events - Demographics
0.24→0.37 mg/kg/week (▲) and 0.37 mg/kg/week ().
Raw data Log-transformed data Male age log age Female age log age
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Nonproliferative DR (n=24)
Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parameters  Hussein Raef, Abdulraof Al-Mahfouz,
Glucose tolerance testing. A
Copyright © 2002 American Medical Association. All rights reserved.
Fig. 1. Fetal GSIS. Fetal plasma glucose (A) and insulin (B) concentrations determined for the in vivo GSIS study are presented as the mean ± sem for control.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2017 American Academy of Pediatrics.
Time frame : Baseline to post intervention
Diabetes Health Status Report
*** *** *** *** *** *** Supplemental Fig. 1 A B N = 27 N = 15
A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids  Sankar Devarajan, PhD, Biprabuddha Chatterjee, MSc, Hidenori Urata,
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.
Hypertension Case Study
A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids  Sankar Devarajan, PhD, Biprabuddha Chatterjee, MSc, Hidenori Urata,
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
GH peak (µg/l) Regression analysis of the GHRH+GHRP-6-elicited GH peaks plotted against body mass index (BMI), in 366 subjects with no endocrine pathology.
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
#significant difference versus baseline (P<.05).
Relationship between karyotype and basal characteristics at GH start
Abnormalities in lipoprotein metabolism in hemodialysis patients
Fig.1. The dose of GH administered to patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th.
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall.
Control Subjects MPHD Patients Control Subjects MPHD Patients
GH dose 12 months of treatment 24 months of treatment Low Medium High
Fig.1 Simple least-squares regression of the relationship between the log of peak GH concentration on standard GH stimulation tests and serum IGF-1 concentrations.
Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose tolerance Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose.
 Gruppe A: 0,033mg WH/kg x die  Gruppe B: 0,067mg WH/kg x die
Height velocity (cm/yr) Height velocity (cm/yr)
STAI: higher scores reflect more anxiety (scores 20-80).
Comparison between groups
(A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group). (A) T2DM: serum glucose levels during glucose tolerance test (n=6 per group).
Growth rate (cm/yr) Estrogen at age 12 Estrogen at age 15
Abbildung mod. nach Van Pareren, 2004
Change in LBM (%)‏ LD CD LD CD LD CD
a b c d OGTT OGTT *** ** * * Blood glucose (mg/dL) AUC (mg/dL/min) ND
David Z. Levine, M.D., Michelle Iacovitti, Kevin D. Burns, Amy Slater 
Dectin-1 is repressed in allergic individuals.
One- to two-hour plasma glucose concentrations over a 24-hour period in patients taking maximal doses of either glyburide (20 mg/day) or glipizide (40.
Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.
Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.
Effect of insulin on hepcidin expression in HepG2 cells.
Glucose, insulin, and AGE levels during an OGC before and after RT
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
Glucose tolerance in WT and TRPM2-KO mice.
Effects of pterosin A on serum levels of lipid, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), and alanine aminotransferase (ALT)
Subchronic glycemic effects after vehicle, metformin, SGLT2I, or combination treatment. Subchronic glycemic effects after vehicle, metformin, SGLT2I, or.
Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance. Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance.
Treatment of ob/ob mice with TTR-ASOs improves insulin sensitivity.
Pioglitazone administration acutely inhibits insulin secretion and increases insulin clearance in Wistar rats. Pioglitazone administration acutely inhibits.
Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). Clinical responses to therapy from baseline.
Effects of d-xylose or sucralose (control) with or without sitagliptin on gastric emptying (half-emptying time [T50]) (n = 12). Effects of d-xylose or.
Fig. 1. The HCN channel blocker ivabradine (IVA) is analgesic in a mouse model of type 1 diabetes. The HCN channel blocker ivabradine (IVA) is analgesic.
Dr Naader Noory`s formulas about diabetes mellitus.
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Presentation transcript:

Effects of 5 yr of GH substitution in 118 GH-deficient adults on serum concentrations of TC, HDL-C, LDL-C and TG as well as on blood glucose, serum insulin and serum HbA1c Serum LDL-C was excluded in five patients due to serum TG values greater than 4.3 mmol/liter. (In all other analyses, the five patients with serum TG values above 4.3 mmol/liter were included). Blood glucose, serum insulin and serum HbA1c were excluded in one patient because this patient had to receive oral medication with glipizide due to diabetes mellitus after 2.5 yr of GH treatment. All values are shown as the mean (SEM). The statistical analyses are based on one-way ANOVA, followed by Student-Newman-Keuls post hoc test. P values (2-5 yr) are based on the post hoc analyses between the 2 yr and 5 yr values. a P<0.05 vs. baseline; b P<0.001 vs. baseline; c P<0.01 vs. baseline Abbildung mod. nach Götherström, 2001